Thalidomide.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy; D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007918:Leprosy / Q000188:drug therapy; D015440:Leprosy, Lepromatous / Q000188:drug therapy; D018919:Neovascularization, Physiologic / Q000187:drug effects; D013281:Stomatitis, Aphthous / Q000188:drug therapy; D013792:Thalidomide / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D000893:Anti-Inflammatory Agents; D013792:Thalidomide